Warm Autoimmune Hemolytic Anemia Linked to Pre-fibrotic Primary Myelofibrosis
Author Information
Author(s): Muacevic Alexander, Adler John R, Lai Steven Y, Lo Amanda E, Wu Phillis
Primary Institution: Olive View University of California Los Angeles (UCLA) Medical Center
Hypothesis
Can warm autoimmune hemolytic anemia (wAIHA) be associated with pre-fibrotic primary myelofibrosis (pre-PMF)?
Conclusion
The case suggests that underlying myelofibrosis should be considered in patients presenting with wAIHA and hematologic abnormalities.
Supporting Evidence
- The patient was treated with high-dose steroids and IVIG, which were unsuccessful, but rituximab led to complete remission.
- A bone marrow biopsy confirmed the diagnosis of pre-fibrotic primary myelofibrosis.
- The patient's condition improved significantly after treatment with rituximab.
Takeaway
A woman with a rare blood condition called warm autoimmune hemolytic anemia was found to have another condition called pre-fibrotic primary myelofibrosis, which made her blood cells behave strangely.
Methodology
The patient underwent treatment with steroids, intravenous immunoglobulin, and rituximab, with a bone marrow biopsy performed for diagnosis.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
64-year-old female with a history of chronic thrombocytosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website